Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Washington
OHSU Knight Cancer Institute
Fox Chase Cancer Center
National Cancer Institute (NCI)
Northwestern University
Northwestern University